GSK251
|
|
|
- CAS号:
- 2125968-05-8
- 英文名:
- 3-Pyridinesulfonamide, N-[2-[2-fluoro-4-[[4-(1-methylethyl)-1-piperazinyl]methyl]phenyl]-4-pyridinyl]-2-methoxy-5-(4-morpholinyl)-
- 英文别名:
- GSK251;GSK251,GSK-251;N-（2-（2-fluoro-4-（（4-isopropylpiperazin-1-yl）methyl）phenyl）pyridin-4-yl）-2-methoxy-5-morpholinopyridine-3-sulfonamide;N-[2-(2-fluoro-4-{[4-(propan-2-yl)piperazin-1-yl]methyl}phenyl)pyridin-4-yl]-2-methoxy-5-(morpholin-4-yl)pyridine-3-sulfonamide;3-Pyridinesulfonamide, N-[2-[2-fluoro-4-[[4-(1-methylethyl)-1-piperazinyl]methyl]phenyl]-4-pyridinyl]-2-methoxy-5-(4-morpholinyl)-
- 中文名:
- GSK251
- 中文别名:
- 化合物GSK251
- CBNumber:
- CB98553231
- 分子式:
- C29H37FN6O4S
- 分子量:
- 584.71
- MOL File:
- 2125968-05-8.mol
|
|
|
GSK251化学性质
-
沸点:
-
742.4±70.0 °C(Predicted)
-
|
-
密度:
-
1.295±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO : 62.5 mg/mL (106.89 mM; ultrasonic and warming and heat to 60°C)
-
|
-
酸度系数(pKa):
-
-0.07±0.10(Predicted)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
Off-white to light yellow
-
|
GSK251性质、用途与生产工艺
GSK251 是一种高效、高选择性、口服生物利用度的PI3Kδ 抑制剂，具有新颖的结合模式。
GSK251
上下游产品信息
上游原料
下游产品
| 更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
|---|
| 2024/08/19 | HY-132880 | GSK251
GSK251 | 2125968-05-8 | 1 mg | 2970元 |
| 2024/08/19 | HY-132880 | GSK251
GSK251 | 2125968-05-8 | 5 mg | 7250元 |
2125968-05-8, GSK251 相关搜索:
- 抑制剂
- 库存
- C29H37FN6O4S
- 化合物GSK251
- 2125968-05-8
- N-[2-(2-fluoro-4-{[4-(propan-2-yl)piperazin-1-yl]methyl}phenyl)pyridin-4-yl]-2-methoxy-5-(morpholin-4-yl)pyridine-3-sulfonamide
- GSK251,GSK-251
- N-（2-（2-fluoro-4-（（4-isopropylpiperazin-1-yl）methyl）phenyl）pyridin-4-yl）-2-methoxy-5-morpholinopyridine-3-sulfonamide
- GSK251
- 3-Pyridinesulfonamide, N-[2-[2-fluoro-4-[[4-(1-methylethyl)-1-piperazinyl]methyl]phenyl]-4-pyridinyl]-2-methoxy-5-(4-morpholinyl)-